<DOC>
	<DOC>NCT01497587</DOC>
	<brief_summary>This trial is conducted in Asia. The aim of this trial is to investigate pharmacokinetics of insulin detemir in healthy Taiwanese subjects.</brief_summary>
	<brief_title>Pharmacokinetics of Insulin Detemir in Healthy Volunteers From Taiwan</brief_title>
	<detailed_description />
	<mesh_term>Insulin, Globin Zinc</mesh_term>
	<mesh_term>Insulin</mesh_term>
	<mesh_term>Insulin Detemir</mesh_term>
	<criteria>Considered generally healthy upon completion of medical history and physical examination as judged by the investigator Body mass index (BMI) between 18 and 27 kg/m^2, inclusive Fasting plasma glucose maximum 6.1 mmol/l Nonsmoker or smoking maximum 5 cigarettes per day or the equivalent Participation in any other clinical trial involving other investigational products within the last 3 months Subject with a history of alcohol or drug dependence Subject with a firstdegree relative with diabetes mellitus</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>January 2017</verification_date>
</DOC>